Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
Blair McNamara, Michelle Greenman, Stefania Bellone, Luca A Santin, Cem Demirkiran, Levent Mutlu, Tobias M.P. Hartwich, Yang Yang‐Hartwich, Elena Ratner, Peter E. Schwartz, Alessandro D. Santin
Topics & Concepts
MedicineTrophoblastConjugateAntibodyAntibody-drug conjugateOvarian carcinomaCancer researchAntigenDrugOvarian cancerImmunologyMonoclonal antibodyPharmacologyCancerInternal medicinePregnancyBiologyFetusPlacentaGeneticsMathematical analysisMathematicsHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCancer Cells and Metastasis